Drug
Sevasemten
Sevasemten is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_2
1
33%
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (66.7%)
Phase 21 (33.3%)
Trials by Status
enrolling_by_invitation133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
enrolling_by_invitationphase_2
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
NCT06066580
completedphase_1
A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy
NCT05160415
completedphase_1
A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers
NCT06916897
Clinical Trials (3)
Showing 3 of 3 trials
NCT06066580Phase 2
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
NCT05160415Phase 1
A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy
NCT06916897Phase 1
A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3